Akt isoforms in vascular disease

Vascular Pharmacology

Volumn 71, Issue , 2015, Pages 57-64

  Yu, Haixiang ^a   Littlewood, Trevor ^a   Bennett, Martin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Akt; Aneurysm; Atherosclerosis; Vascular diseases

Indexed keywords

PROTEIN KINASE B; AKT2 PROTEIN, HUMAN; AKT3 PROTEIN, HUMAN; ISOPROTEIN;

ANEURYSM; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS BY BODY ANATOMY; ENDOTHELIUM CELL; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR LESION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CELL MOTION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84937970392     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.03.003     Document Type: Review

References (87)

1. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. TIBS 2001, 26(11):657-664.
2. Bellacosa A., Testa J.R., Staal S.P., Tsichlis P.N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991, 254(5029):274-277.
3. Hixon M.L., Muro-Cacho C., Wagner M.W., Obejero-Paz C., Millie E., Fujio Y., et al. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 2000, 106(8):1011-1020.
4. Ackah E., Yu J., Zoellner S., Iwakiri Y., Skurk C., Shibata R., et al. Akt1/protein kinase B alpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 2005, 115(8):2119-2127.
5. Lawlor M.A., Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci 2001, 114(Pt 16):2903-2910.
6. Tucka J., Bennett M., Littlewood T. Cell death and survival signalling in the cardiovascular system. Front Biosci 2012, 17:248-261.
7. Chan TO, Rittenhouse S.E., Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999, 68:965-1014.
8. Hanada M., Feng J., Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta 2004, 1697(1-2):3-16.
9. Dummler B., Tschopp O., Hynx D., Yang Z.Z., Dirnhofer S., Hemmings B.A. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 2006, 26(21):8042-8051.
10. Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. J Cell Sci 2005, 118(Pt 24):5675-5678.
11. Gonzalez E., McGraw T.E. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 2009, 8(16):2502-2508.
12. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001, 15(17):2203-2208.
13. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001, 276(42):38349-38352.
14. Garofalo R.S., Orena S.J., Rafidi K., Torchia A.J., Stock J.L., Hildebrandt A.L., et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 2003, 112(2):197-208.
15. Tschopp O., Yang Z.Z., Brodbeck D., Dummler B.A., Hemmings-Mieszczak M., Watanabe T., et al. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005, 132(13):2943-2954.
16. Gonzalez E., McGraw T.E. Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc Natl Acad Sci U S A 2009, 106(17):7004-7009.
17. Santi S.A., Lee H. The Akt isoforms are present at distinct subcellular locations. Am J Physiol Cell Physiol 2010, 298(3):C580-C591.
18. Ding L., Biswas S., Morton R.E., Smith J.D., Hay N., Byzova T.V., et al. Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab 2012, 15(6):861-872.
19. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005, 115(8):2108-2118.
20. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129(7):1261-1274.
21. Bellacosa A., Kumar C.C., Di Cristofano A., Testa J.R. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005, 94:29-86.
22. Shiojima I., Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 2006, 20(24):3347-3365.
23. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7(8):589-600.
24. Shiojima I., Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002, 90(12):1243-1250.
25. O'Neill B.T., Abel E.D. Akt1 in the cardiovascular system: friend or foe?. J Clin Invest 2005, 115(8):2059-2064.
26. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995, 95:2266-2274.
27. Harrington E.A., Bennett M.R., Fanidi A., Evan G.I. c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994, 13:3286-3295.
28. Bai H.Z., Pollman M.J., Inishi Y., Gibbons G.H. Regulation of vascular smooth muscle cell apoptosis-modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 1999, 85(3):229-237.
29. Chung J., Grammer T.C., Lemon K.P., Kazlauskas A., Blenis J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994, 370(6484):71-75.
30. Hawkins P.T., Eguinoa A., Qiu R.G., Stokoe D., Cooke F.T., Walters R., et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol 1995, 5(4):393-403.
31. Kobayashi T., Cohen P. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 1999, 339(Pt 2):319-328.
32. Park J., Leong M.L., Buse P., Maiyar A.C., Firestone G.L., Hemmings B.A. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 1999, 18(11):3024-3033.
33. Park J., Hill M.M., Hess D., Brazil D.P., Hofsteenge J., Hemmings B.A. Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 (PDK1) and their role in regulating kinase activity. J Biol Chem 2001, 276(40):37459-37471.
34. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376(6541):599-602.
35. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81(5):727-736.
36. Datta S., Brunet A., Greenberg M. Cellular survival: a play in three Akts. Genes Dev 1999, 13:2905-2927.
37. Kauffman Zeh A., Rodriguez Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI3K and PKB. Nature 1997, 385(6616):544-548.
38. Franke T., Kaplan D., Cantley L., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4 bi-phosphate. Science 1997, 275:665-668.
39. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275(5300):661-665.
40. Philpott K., McCarthy M., Klippel A., Rubin L. Activated phosphatidylinositol 3-kinase and atk kinase promote survival of superior cervical neurons. J Cell Biol 1997, 139:809-815.
41. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S. Serine phosphorylation of death agonist bad in response to survival factor results in binding to 14-3-3 not Bcl-X1. Cell 1996, 87:619-628.
42. Cardone M., Roy N., Stennicke H., Salveson G., Franke T., Stanbridge E., et al. Regulation of cell death protease caspase 9 by phosphorylation. Science 1998, 282:1318-1321.
43. Maurer U., Charvet C., Wagman A.S., Dejardin E., Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006, 21(6):749-760.
44. Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 2001, 21(3):952-965.
45. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96(6):857-868.
46. Nakae J., Barr V., Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 2000, 19(5):989-996.
47. Jones R., Parsons M., Bonnard M., Chan V., Yeh W.-C., Woodgett J., et al. Protein kinase B regulates T lymphocyte survival, Nuclear Factor kB activation and Bcl-XL levels in vitro. J Exp Med 2000, 191:1721-1733.
48. Papapetropoulos A., Fulton D., Mahboubi K., Kalib R., O'Connor D., Li F., et al. Angiopoetin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 2000, 275:9102-9105.
49. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401(6748):86-90.
50. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000, 20(5):1626-1638.
51. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
52. Fulton D., Gratton J.-P., McCabe T., Fontana J., Fujio Y., Walsh L., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
53. Allard D., Figg N., Bennett M.R., Littlewood T.D. Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3. J Biol Chem 2008, 283(28):19739-19747.
54. Shen Y.H., Zhang L., Ren P., Nguyen M.T., Zou S., Wu D., et al. AKT2 confers protection against aortic aneurysms and dissections. Circ Res 2013, 112(4):618-632.
55. Stabile E., Zhou Y.F., Saji M., Castagna M., Shou M., Kinnaird T.D., et al. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 2003, 93(11):1059-1065.
56. Fernandez-Hernando C., Jozsef L., Jenkins D., Di Lorenzo A., Sessa W.C. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(12):2033-2040.
57. Mukai Y., Rikitake Y., Shiojima I., Wolfrum S., Satoh M., Takeshita K., et al. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest 2006, 116(2):334-343.
58. Tucka J., Yu H., Gray K., Figg N., Maguire J., Lam B., et al. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis. Arterioscler Thromb Vasc Biol 2014, 34(11):2421-2428.
59. Rensing K.L., de Jager S.C., Stroes E.S., Vos M., Twickler M.T., Dallinga-Thie G.M., et al. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Cardiovasc Res 2014, 101(2):277-287.
60. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112(4):453-465.
61. Bugyi B., Carlier M.F. Control of actin filament treadmilling in cell motility. Annu Rev Biophys 2010, 39:449-470.
62. Qian Y., Corum L., Meng Q., Blenis J., Zheng J.Z., Shi X., et al. PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am J Physiol Cell Physiol 2004, 286(1):C153-C163.
63. Morales-Ruiz M., Fulton D., Sowa G., Languino L.R., Fujio Y., Walsh K., et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 2000, 86(8):892-896.
64. Di Lorenzo A., Fernandez-Hernando C., Cirino G., Sessa W.C. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A 2009, 106(34):14552-14557.
65. Babaev V.R., Hebron K.E., Wiese C.B., Toth C.L., Ding L., Zhang Y., et al. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice. J Lipid Res 2014, 55(11):2296-2308.
66. Rotllan N., Chamorro-Jorganes A., Araldi E., Wanschel A.C., Aryal B., Aranda J.F., et al. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis. FASEB J 2015, 29(2):597-610.
67. Chen J., Tang H., Hay N., Xu J., Ye R.D. Akt isoforms differentially regulate neutrophil functions. Blood 2010, 115(21):4237-4246.
68. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med 2005, 11(11):1188-1196.
69. Lee M.Y., Luciano A.K., Ackah E., Rodriguez-Vita J., Bancroft T.A., Eichmann A., et al. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc Natl Acad Sci U S A 2014, 111(35):12865-12870.
70. Somanath P.R., Razorenova O.V., Chen J., Byzova T.V. Akt1 in endothelial cell and angiogenesis. Cell Cycle 2006, 5(5):512-518.
71. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399(6736):597-601.
72. Allen T.R., Krueger K.D., Hunter W.J., Agrawal D.K. Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis. Immunol Cell Biol 2005, 83(6):651-667.
73. Fernandez-Hernando C., Ackah E., Yu J., Suarez Y., Murata T., Iwakiri Y., et al. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab 2007, 6(6):446-457.
74. Zhang Y., Wang X., Yang H., Liu H., Lu Y., Han L., et al. Kinase AKT controls innate immune cell development and function. Immunology 2013, 140(2):143-152.
75. Gantner B.N., Jin H., Qian F., Hay N., He B., Ye R.D. The Akt1 isoform is required for optimal IFN-beta transcription through direct phosphorylation of beta-catenin. J Immunol 2012, 189(6):3104-3111.
76. Androulidaki A., Iliopoulos D., Arranz A., Doxaki C., Schworer S., Zacharioudaki V., et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31(2):220-231.
77. Arranz A., Doxaki C., Vergadi E., Martinez de la Torre Y., Vaporidi K., Lagoudaki E.D., et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 2012, 109(24):9517-9522.
78. Clarke M.C., Figg N., Maguire J.J., Davenport A.P., Goddard M., Littlewood T.D., et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12(9):1075-1080.
79. Clarke M.C., Littlewood T.D., Figg N., Maguire J.J., Davenport A.P., Goddard M., et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008, 102(12):1529-1538.
80. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010, 10(1):36-46.
81. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 2005, 115(8):2128-2138.
82. Yun S.J., Ha J.M., Kim E.K., Kim Y.W., Jin S.Y., Lee D.H., et al. Akt1 isoform modulates phenotypic conversion of vascular smooth muscle cells. Biochim Biophys Acta 2014, 1842(11):2184-2192.
83. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms. J Vasc Surg 1991, 13(3):452-458.
84. Henderson E.L., Geng Y.J., Sukhova G.K., Whittemore A.D., Knox J., Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99(1):96-104.
85. Daugherty A., Powell J.T. Recent highlights of ATVB: aneurysms. Arterioscler Thromb Vasc Biol 2014, 34(4):691-694.
86. Lopez-Candales A., Holmes D.R., Liao S., Scott M.J., Wickline S.A., Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997, 150(3):993-1007.
87. Ghosh A., Lu G., Su G., McEvoy B., Sadiq O., DiMusto P.D., et al. Phosphorylation of AKT and abdominal aortic aneurysm formation. Am J Pathol 2014, 184(1):148-158.